Trader: Low Volume ...
Health Care: Drugs
Cyclacel Pharmaceuticals Inc. (CYCC: NASDAQ)
$0.52 -0.07 | -11.86%
06/04/12 - 03:59 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 699.00K | 686.00K | 911.00K | 877.00K |
| Cost of Sales | 119.00K | -39.00K | -145.00K | -68.00K |
| Gross Operating Profit | 580.00K | 725.00K | 1.06M | 945.00K |
| Selling, General, and Administrative Expenses | 7.52M | 10.12M | 8.54M | 15.35M |
| Research & Development | 9.21M | 6.41M | 9.77M | 18.87M |
| Operating Income before D & A (EBITDA) | -16.15M | -15.81M | -17.25M | -33.28M |
| Depreciation & Amortization | 241.00K | 457.00K | 690.00K | 497.00K |
| Interest Income | 45.00K | 37.00K | 102.00K | 1.38M |
| Other Income - Net | 535.00K | -406.00K | -2.14M | -999.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | -7.93M |
| Total Income Before Interest Expenses (EBIT) | -15.81M | -16.64M | -20.34M | -41.82M |
| Interest Expense | 0.00 | 43.00K | 177.00K | 318.00K |
| Pre-Tax Income | -15.81M | -16.68M | -20.52M | -42.14M |
| Income Taxes | -565.00K | -657.00K | -948.00K | -1.75M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -15.24M | -16.02M | -19.57M | -40.39M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -15.24M | -16.02M | -19.57M | -40.39M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -15.24M | -16.02M | -19.57M | -40.39M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-15.24M | -16.02M | -19.20M | -31.96M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -15.97M | -19.70M | -19.57M | -40.39M |
| Basic EPS from Continuing Ops. | -0.32 | -0.52 | -0.88 | -1.98 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.32 | -0.52 | -0.88 | -1.98 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.32 | -0.52 | -0.88 | -1.98 |
| Basic Normalized Net Income/Share | -0.32 | -0.52 | -0.86 | -1.57 |
| EPS fr Continuing Ops. | -0.32 | -0.52 | -0.88 | -1.98 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.32 | -0.52 | -0.88 | -1.98 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.32 | -0.52 | -0.88 | -1.98 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.32 | -0.52 | -0.86 | -1.57 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CYCC
- Portfolio NameUser Type
- Uservlady 1
- Contributor13 Biotech Stocks Bought an...
- ProWilbur Ross - Invesco Priva...
- Contributor10 Cheap Biotech Stocks Tha...
- Userjeezlola
- Contributor10 Biotech Stocks Expected ...
- UserJSD Holdings
- UserBesV Portfolio 1
- UserStock2009
- UserTdawg
Latest CYCC Headlines from TheStreet
- Friday's Top 10 Articles, Videos on TheStreet 03.02.12 | 01:03 pm
- Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash 03.02.12 | 05:03 am
- BIO CEO Conference Live Blog 02.13.12 | 01:02 pm
- The Worst Biotech CEO of 2011 Is ... 12.09.11 | 07:12 am
- The Biotech Stock 13F Review: What Hedge Funds Were Buying and Selling 11.16.11 | 08:11 am
- Biotech Stock Mailbag: Somaxon, Transcept 10.07.11 | 06:10 am
- Biotech Stock Mailbag: Research Backs Shorting Micro-Cap Cancer Drug Stocks 09.30.11 | 05:09 am
- Biotech Stock Mailbag: Cyclacel Pharma 08.12.11 | 05:08 am
- Cyclacel Stock Gaps Down On Today's Open (CYCC) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Ranking Cheap Biotechs 07.01.11 | 08:07 am
Press Releases for CYCC
Partner Headlines for CYCC
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Cyclacel: An Intriguing Long Shot - Seeking Alpha 03.20.12 | 08:03 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.18.11 | 09:11 am
- Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners - Seeking Alpha 09.29.11 | 08:09 am
- The Biotech Bump: Cyclacel Pharmaceuticals - Benzinga 07.28.11 | 01:07 pm
- Profit From These 3 Analysts' Stock Picks for Under $10 - Seeking Alpha 07.13.11 | 09:07 am
- Cyclacel Pharmaceuticals Files S-3 $75M Mixed Securities Shelf - Benzinga 04.04.11 | 04:04 pm
- US scientists recreate heart defect in a lab dish - Reuters 02.09.11 | 01:02 pm
- Pfizer, Adolor End Collaboration to Develop Pain Meds: Biotech's Latest Troubles - Seeking Alpha 12.26.10 | 01:12 am
